Australian-based anti-infective drug developer
Biota Holdings (ASX:BTA) has acquired the assets and drug development programs of MaxThera, Inc, an antibacterial drug discovery company located in Boston, USA.As consideration,
Biota will pay MaxThera for ...
[Proactive Investors.co.uk - 11/12/2009]